About the NCL
Mission - Cancer Nanotechnology Plan - Management & Administration
Staff - Facilities - Career Opportunities
In addition to collaborative resources located at NIST, the NCL will also have direct access to all resources at the Frederick National Laboratory for Cancer Research (FNL), including those co-located with the NCL at the Advanced Technology Research Facility. The laboratories in of the NCL are outfitted with a tissue culture room, an isotope laboratory, research bays, a cold room, a chromatography and electrophoresis area, microscopy rooms, a spectroscopy area, a synthetic lab with chemical fume hoods, and open floor space for freestanding instrumentation and equipment.
Relationship to Leidos Biomedical Research
The NCL is a government-owned, contractor-operated (GOCO) facility under NCI's federally funded research and development center (FFRDC) and will fall under NCI-Frederick's Operations and Technical Support (OTS) contract. Leidos Biomedical Research, Inc., a subsidiary of Leidos, is the OTS contractor for the Frederick National Laboratory for Cancer Research. The mission of Leidos Biomedical Research, Inc., is to provide scientific, technical, management, administrative, and logistical support to NIH intramural laboratory research and development related to the causes of and cures for cancer and AIDS.
Leidos Biomedical Research, Inc., is one of four related NCI contracts on site and serves as the infrastructure support for the entire center. The contract is the largest single research contract awarded by the U.S. Department of Health and Human Services (DHHS) and it is the Department's only government-owned, contractor-operated facility contract. Leidos Biomedical Research, Inc. employs over 1,500 staff including scientists, research assistants, technicians, engineers, administrative, maintenance, and support personnel.
Leidos Biomedical Research operates under a variety of regulatory, performance, and quality standards.
A Service of the National Cancer Institute